PETALING JAYA: There is still some caution over electronics manufacturing services provider Inari Amertron Bhd
’s outlook, despite signs of recovery of the key radio frequency (RF) business in the company’s first quarter ended Sept 30, 2026 (1Q27) results released on Nov 18 that have largely met expectations.
Analysts were largely positive on the longer-term outlook for the company and expect earnings recovery in financial year ending June 30, 2027 (FY27) as volume loading across all business segments as well as margins recover.
MBSB Research anticipates better earnings momentum in the quarters ahead on a gradual pick-up in the datacom business and recovery in the volume loading for the RF business.
It has maintained a “buy” recommendation on the stock with a target price (TP) of RM2.95 following the 1Q27 results.
RHB Research has also kept a “buy” call on the stock with a TP of RM2.77 as it noted that growth in 1Q27 was on strong loading across business segments fuelled by accelerated growth from optoelectronics products and a seasonally strong RF business.
“We believe FY27 is set to be a growth year, where the datacom, automotive, and industrial segments are set to accelerate.
“Inari Amertron’s current share price weakness presents a good opportunity to accumulate and position for the ramp-up in the optical transceivers business,” it added.
It noted that the run-rate for the chipfab process for a major customer would support the company’s strong double-digit growth in FY27, coupled with a stronger run-rate for the final assembly at its Philippines operations.
While BIMB Research has reiterated a “buy” rating on the stock, it has lowered the TP to RM2.35 from RM2.90.
“We came away from the results slightly less optimistic on the pace of earnings recovery but remain positive on Inari’s longer-term growth trajectory,” it said.
The brokerage said 1Q27’s performance reinforced its view of RF demand recovery, although not at the rate experienced during the past upcycle.
It has slightly trimmed earnings projections by 18.9% for FY27, while FY28 and FY29 projections have been trimmed by 17.7% and 15.7%.
“In our view, the more important development is the company’s ongoing progress in photonics, which is gradually transforming the investment narrative from a cyclical recovery story to one centred on structural growth opportunities.
“As customer engagements expand and projects move closer to commercialisation, investor focus is likely to gradually shift towards Inari’s execution capabilities and ability to scale these new businesses into meaningful earnings contributors,” it added.
TA Research has upgraded the stock to a “buy” call from a “hold” call on recent share price weakness with a TP of RM2.70 based on price-earnings (PE) multiple of 36 times 2027 earnings per share (EPS).
Apex Research stays “positive” on the stock going into the second half of FY27 (2H27) as the company expands the photonics and advanced packaging pipeline alongside the existing RF business.
It has also maintained a “buy” call on the stock with a TP of RM2.94 based on an unchanged 37.7 times PE applied to FY28 core EPS of 7.8 sen, which captures the first full year of the expanded photonics capacity.
Meanwhile, core net profit forecasts for FY27 to FY29 have been maintained at RM258.7mil/RM298.1mil/RM339.6mil respectively as 1Q27 tracked the house’s expectations with “customer B” and photonics contributions concentrated in the 2H27 into FY28.
